Understanding medical cannabis use internationally: Why definitions and context matter
Abstract Aims: To identify variation in identification of medical consumers using alternative self‐reported measures and assess whether differences in these…
Myfanwy Graham
The safety and efficacy of cannabinoids for the treatment of mental health and substance use disorders: protocol for a systematic review and meta-analysis
Abstract There has been a global increase in the use of cannabinoids as a treatment for mental health (MH) and…
NSW cannabis medicines advisory service retrospective enquiry analysis to inform clinical guidance resource development
Abstract Background: An innovative New South Wales government funded statewide Cannabis Medicines Advisory Service (CMAS) operated between January 2018 and…
From growers to patients: Multi-stakeholder views on the use of, and access to medicinal cannabis in Australia
Abstract Background: Patient interest in the use of cannabis-based medicines (CBMs) has increased in Australia. While recent policy and legislative…
Opioid-sparing effect of cannabinoids for analgesia: an updated systematic review and meta-analysis of preclinical and clinical studies
Abstract Cannabinoid co-administration may enable reduced opioid doses for analgesia. This updated systematic review on the opioid-sparing effects of cannabinoids…
Expert advice for prescribing cannabis medicines for patients with epilepsy—drawn from the Australian clinical experience
Abstract There is international interest for consensus advice for prescribers working in the field of drug resistant epilepsy intending to…
NSW Cannabis Medicines Advisory Service preliminary survey results: enquirer perceptions and patient outcomes
Abstract Background: In 2018, an innovative, State government‐funded cannabis medicines drug information service was established for health professionals in New…